| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/03/2002 | CN1342474A Functional additive for cosmetics |
| 04/03/2002 | CN1342464A Antivirus antioxidizing active extract of proplis and its molecular inclusion compound |
| 04/03/2002 | CN1342452A Foaming emulsion for treating fatty skin |
| 04/03/2002 | CN1081929C Health preparation of fresh Chinese angelica and its preparation |
| 04/03/2002 | CN1081925C Oil ointment of chirita longangensis for treating hurns and its preparation method |
| 04/03/2002 | CN1081919C Preparation for skin and mucous membrane |
| 04/03/2002 | CN1081914C Deodorization powder for foot |
| 04/02/2002 | US6365768 Interleukin-1 and tumor necrosis factors-α modulators, syntheses of said modulators and methods of using modulators |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365736 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365664 Gels formed by the interaction of poly(aldehyde) with various substances |
| 04/02/2002 | US6365656 Liquid dispersion polymer compositions, their preparation and their use |
| 04/02/2002 | US6365630 Compositions and methods for inhibiting photoaging of skin |
| 04/02/2002 | US6365623 Treatment of acne using lipoic acid |
| 04/02/2002 | US6365616 Transplant rejection |
| 04/02/2002 | US6365612 Benzosultam oxazolidinone antibacterial agents |
| 04/02/2002 | US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/02/2002 | US6365597 4-aza steroids |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365583 Methods to enhance white blood cell count |
| 04/02/2002 | US6365572 For therapy of diseases related to increased or unwanted synthesis of basement membranes such as diabetes mellitus; atherosclerosis; cancer; diabetic retinopathia; fibroplasia retrolentalis; or psoriasis, rheumatoic arthritis |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365166 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1h-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 04/02/2002 | US6365145 Using liposome; applying light |
| 04/02/2002 | US6365135 Bleaching human skin, hair |
| 04/02/2002 | CA2357961A1 Method for reduction of inflammation and erythema |
| 04/02/2002 | CA2357958A1 Method for promoting clear skin |
| 04/02/2002 | CA2357925A1 Prophylactic use of n-methyl-d-asparate (nmda) antagonists |
| 04/02/2002 | CA2194798C Cosmetic compositions for the skin and/or hair photoprotection which are based on a sinergic mixture of filters, and uses thereof |
| 04/02/2002 | CA2056066C A physical form of n-[4-[5-(cyclopentyloxycarbony)amino-1-methylindol-3yl-methy1]-3-methoxybenzoy1]-2-methlbenzenesulphonamide, processes for its preparation and compositions containing it |
| 03/29/2002 | CA2321406A1 Restoration of perturbed barrier function by application of antiandrogens |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024903A1 Method of examining allergic disease |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024711A1 Novel thiazole bicyclic compounds |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024697A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
| 03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024679A1 PYRIDINE DERIVATIVES WITH IKB-KINASE (IKK-β) INHIBITING ACTIVITY |
| 03/28/2002 | WO2002024674A1 Benzoic acid derivatives and uses thereof |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024651A1 A process for producing 2-amino-4,6-disubstituted nicotinic acid ester analogs |
| 03/28/2002 | WO2002024613A2 Resorcinol derivatives |
| 03/28/2002 | WO2002024609A2 Method for producing a radioprotector |
| 03/28/2002 | WO2002024307A2 Reducing the content of particular cell types in a biological sample |
| 03/28/2002 | WO2002024226A2 Photosensitisers |
| 03/28/2002 | WO2002024222A2 Ligands for g protein coupled receptors and methods of using them |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2002024218A1 Angiogenic agents and their uses |
| 03/28/2002 | WO2002024206A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 03/28/2002 | WO2002024194A2 Use of statins (hmg-coa reductase inhibitors) for the preparation of medicament as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 03/28/2002 | WO2002024189A1 Cell activator |
| 03/28/2002 | WO2002024162A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | WO2002002056A3 Method of treatment of seborrheic dermatitis |
| 03/28/2002 | WO2001096336A3 6,5-fused bicyclic heterocycles |
| 03/28/2002 | WO2001087236B1 Topical administration of pharmacological compositions for non-systemic treatment of pruritus |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001085182A3 Combined cartilage and plant extract compositions |
| 03/28/2002 | WO2001079249A3 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them |
| 03/28/2002 | WO2001072287A3 Use of ectoin or ectoin derivatives for the prophylaxis and/or treatment of uv-induced immunosuppression |
| 03/28/2002 | WO2001066107A3 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 03/28/2002 | WO2001051044A3 Substances for use in treating psoriasis |
| 03/28/2002 | WO2001043756A3 Regenerative adjuvant |
| 03/28/2002 | WO2001035936A3 Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides for the treatment of diseases |
| 03/28/2002 | WO2001032216A3 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 03/28/2002 | WO2001019353A3 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 03/28/2002 | WO2001007405A3 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 03/28/2002 | WO2000063241A9 Methods and compositions for modulating an immune response |
| 03/28/2002 | WO2000056327A9 Ascorbic acid composition and method for treatment of aging or damaged skin |
| 03/28/2002 | WO2000047722A3 Chimeric virus-like particles or chimeric capsomers from bvp (bovine papilloma virus) |
| 03/28/2002 | US20020038030 For therapy of inflammatory conditions including migraine, rheumatoid arthritis, asthma, and inflammatory bowel disease as well as mediation of the emetic reflex and the modulation of central nervous system (CNS) disorders such as Parkinson's |
| 03/28/2002 | US20020038002 To suppress immune system for therapy of symptoms associated with immune disorders such as allergies, transplanted tissue rejection and autoimmune diabetes, rheumatoid arthritis and multiple sclerosis |
| 03/28/2002 | US20020037927 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/28/2002 | US20020037924 Small molecule carbamate or urea hair growth compositions and uses |
| 03/28/2002 | US20020037919 Compositions and methods of paclitaxel for preventing psoriasis |
| 03/28/2002 | US20020037915 4-(4-(1- phenyl-5-propylpyrazol4-yl)(1,3-thiazol-2-yl))-5-methylthiothiophene-2 -carboxamidine, for example; complement inhibitors; treating tissue damage, inflammation, or autoimmune diseases |
| 03/28/2002 | US20020037914 Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| 03/28/2002 | US20020037909 Enamine derivatives |
| 03/28/2002 | US20020037900 Hydroxamic acid derivatives |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/28/2002 | US20020037880 Method of inhibiting hair growth |
| 03/28/2002 | US20020037878 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/28/2002 | US20020037874 Anticoagulants |
| 03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
| 03/28/2002 | US20020037574 Recombinant C-proteinase and processes, methods and uses thereof |
| 03/28/2002 | US20020037538 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037291 Sphingoglycolipid |
| 03/28/2002 | US20020037272 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 03/28/2002 | US20020037268 Antimicrobial sanitizing lotion with skin protection properties |
| 03/28/2002 | US20020037266 Hair cosmetic composition |
| 03/28/2002 | CA2424394A1 Growth factor complex comprising an insulin-like growth factor binding protein bound to vitronectin |
| 03/28/2002 | CA2423262A1 Resorcinol derivatives |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |